Verona Stock Soars After $200m Placement For COPD Drug

Fundraise Nearly Quadruples Market Cap

 
• By Kevin Grogan
Leaves_Lungs
Verona could bring the first new class of COPD drugs in decades to market • Source: Shutterstock

More from Financing

More from Business